These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15585308)

  • 1. Soluble chemokine CCR5 receptor is present in human plasma.
    Tsimanis A; Kalinkovich A; Bentwich Z
    Immunol Lett; 2005 Jan; 96(1):55-61. PubMed ID: 15585308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine.
    Misumi S; Nakajima R; Takamune N; Shoji S
    J Virol; 2001 Dec; 75(23):11614-20. PubMed ID: 11689643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular cloning and functional expression of the dog CCR5.
    Mosley M; Pullen S; Botham A; Gray A; Napier C; Mansfield R; Holbrook M
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):415-20. PubMed ID: 16806494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
    Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
    Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
    Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
    J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
    Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization.
    Sun L; Abdelwahab SF; Lewis GK; Garzino-Demo A
    Int Immunol; 2004 Nov; 16(11):1623-31. PubMed ID: 15466454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
    Baba M; Takashima K; Miyake H; Kanzaki N; Teshima K; Wang X; Shiraishi M; Iizawa Y
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4584-91. PubMed ID: 16251299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
    AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
    Nisius L; Rogowski M; Vangelista L; Grzesiek S
    Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years.
    Briz V; Poveda E; López M; González Mdel M; Soriano V; Benito JM
    AIDS; 2008 Jul; 22(11):1371-4. PubMed ID: 18580618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of HIV-1 RNA load after HAART interruption: relationship with CCR5 co-receptor density and proviral DNA load in HIV-infected patients.
    Soriano-Sarabia N; Vallejo A; Fernández G; Genebat M; Gutiérrez S; Muñoz-Fernández MA; Leal M
    J Clin Virol; 2007 Sep; 40(1):64-7. PubMed ID: 17662650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
    Badewa AP; Quinton LJ; Shellito JE; Mason CM
    Tuberculosis (Edinb); 2005 May; 85(3):185-95. PubMed ID: 15850756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc.
    Demarest JF; Sparks SS; Schell K; Shibayama S; McDanal CB; Fang L; Adkison KK; Shachoy-Clark A; Piscitelli SC
    J Clin Pharmacol; 2008 Oct; 48(10):1179-88. PubMed ID: 18676693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10-Methoxydihydrofuscin, fuscinarin, and fuscin, novel antagonists of the human CCR5 receptor from Oidiodendron griseum.
    Yoganathan K; Rossant C; Ng S; Huang Y; Butler MS; Buss AD
    J Nat Prod; 2003 Aug; 66(8):1116-7. PubMed ID: 12932138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.